Zoledronic Acid Injection
Product Images NDC 68083-256

4 FDA label images from Gland Pharma Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Zoledronic Acid (NDC 68083-256). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Zoledronic-structure (Zoledronic Structure)

Zoledronic-structure (Zoledronic Structure)
Chemical structure of zoledronic acid showing a pyridine ring attached to a carbon bearing two phosphonic acid groups and a hydroxyl group with a water molecule.*
FDA Label Image

Zoledronic-figure1 (Zoledronic Figure1)

Zoledronic-figure1 (Zoledronic Figure1)
A Kaplan-Meier plot showing the time to first hip fracture over 36 months comparing placebo and zoledronic acid groups. The y-axis represents the cumulative incidence, with zoledronic acid showing a lower fracture incidence compared to placebo. The plot includes a p-value of 0.0024 from a stratified log-rank test.*
FDA Label Image

Zoledronic-figure2 (Zoledronic Figure2)

Zoledronic-figure2 (Zoledronic Figure2)
Two bar graphs showing comparative data over time between Zoledronic acid and Risedronate. The first graph, titled Therapeutic Response Over Time, presents response percentages across days 10 to 182. The second graph, Serum Alkaline Phosphatase (SAP) Normalization Over Time, shows SAP normalization percentages over days 0 to 182. Statistically significant differences (P < 0.001) are marked on both graphs.*
FDA Label Image

Zoledronic-bag-label (Zoledronic Bag Label)

Zoledronic-bag-label (Zoledronic Bag Label)
Zoledronic Acid Injection 5 mg per 100 mL sterile solution for intravenous infusion by Gland Pharma Limited. The label states the NDC 68083-256-01 and includes usage instructions, storage conditions at 25°C with excursions, and pharmacist dispensing note for a medication guide. It also notes the solution is preservative-free, DEHP-free, and PVC-free.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.